Sagimet Biosciences (SGMT) Earnings Date, Estimates & Call Transcripts $9.15 +0.47 (+5.41%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$8.95 -0.20 (-2.17%) As of 07/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sagimet Biosciences Earnings Summary Sagimet Biosciences announced Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.56, which beat the consensus estimate of -$0.79 by $0.23. With a trailing EPS of -$1.76, Sagimet Biosciences' earnings are expected to decrease next year, from ($1.60) to ($4.03) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 8) -$0.79 Actual EPS (May. 8) -$0.56 Beat By $0.23 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SGMT Upcoming EarningsSagimet Biosciences' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Sagimet Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sagimet Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSGMT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Sagimet Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.00-$1.00-$1.00Q2 20251-$1.22-$1.22-$1.22Q3 20251-$1.31-$1.31-$1.31Q4 20251-$1.34-$1.34-$1.34 Sagimet Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/8/2025Q1 2025-$0.79-$0.56+$0.23-$0.56--3/12/2025Q4 2024-$0.65-$0.50+$0.15-$0.50--8/14/2024--$0.34-$0.25+$0.09-$0.25--5/15/2024Q1 2024-$0.41-$0.23+$0.18-$0.23--11/13/2023Q3 2023-$1.02-$0.35+$0.67-$0.35-$2.00M8/21/2023Q2 2023-$0.50-$35.80 -$35.30-$35.80-- Sagimet Biosciences Earnings - Frequently Asked Questions When is Sagimet Biosciences' earnings date? Sagimet Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on SGMT's earnings history. Did Sagimet Biosciences beat their earnings estimates last quarter? In the previous quarter, Sagimet Biosciences (NASDAQ:SGMT) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.23. Learn more on analysts' earnings estimate vs. SGMT's actual earnings. How much revenue does Sagimet Biosciences generate each year? Sagimet Biosciences (NASDAQ:SGMT) has a recorded annual revenue of $2 million. How much profit does Sagimet Biosciences generate each year? Sagimet Biosciences (NASDAQ:SGMT) has a recorded net income of -$45.57 million. SGMT has generated -$1.76 earnings per share over the last four quarters. What is Sagimet Biosciences' EPS forecast for next year? Sagimet Biosciences' earnings are expected to decrease from ($1.60) per share to ($4.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies Collegium Pharmaceutical Earnings Results Akebia Therapeutics Earnings Results Spyre Therapeutics Earnings Results Mineralys Therapeutics Earnings Results Avadel Pharmaceuticals Earnings Results Pharvaris Earnings Results Nurix Therapeutics Earnings Results Ardelyx Earnings Results Oric Pharmaceuticals Earnings Results Praxis Precision Medicines Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:SGMT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGMT Stock Alerts